Leukocare: Funding, Investors & Team (Sep 2026)
Leukocare is a biotechnology company specialized in the field of biopharmaceutical formulation development. Operating at the interface of drug substance and drug product development, Leukocare combines sound knowledge of formulation development with bioinformatics and artificial intelligence.
Leukocare has raised $15.0M across 1 funding round on record, the most recent an undisclosed round of $15.0M announced in Jun 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Leukocare Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Leukocare Funding Rounds
Leukocare Founders and Leadership Team
No contact details are on record for this team yet.
Leukocare Funding Compared to Other Biotechnology Startups
Leukocare's latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Leukocare in Biotechnology and Martinsried
Companies Similar to Leukocare
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Leukocare Funding FAQs
What does Leukocare do?
Leukocare is a biotechnology company specialized in the field of biopharmaceutical formulation development. Operating at the interface of drug substance and drug product development, Leukocare combines sound knowledge of formulation development with bioinformatics and artificial intelligence.
How much funding has Leukocare raised?
Leukocare has raised $15.0M across 1 round on record. The most recent is an undisclosed round of $15.0M announced in Jun 2021.
When did Leukocare last raise funding?
Leukocare's most recent funding round on record is an undisclosed round of $15.0M, announced in Jun 2021.
Who is the CEO of Leukocare?
Michael Scholl is listed as CEO at Leukocare.
Where is Leukocare headquartered?
Leukocare is based in Martinsried, Bayern, Germany.
How many employees does Leukocare have?
Leukocare is in the 11-50 employee band.
How does Leukocare's funding compare to other Biotechnology startups?
Leukocare's latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Leukocare Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Leukocare is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.